Zolgensma
onasemnogene abeparvovec-xioi · KIT · Novartis Gene Therapies, Inc.
No Recall History
Plain English
Zolgensma is a kit containing onasemnogene abeparvovec-xioi. Manufactured by Novartis Gene Therapies, Inc..
Key Facts
- Brand Name
- Zolgensma
- Generic Name
- onasemnogene abeparvovec-xioi
- NDC Code (Product)
71894-149- Manufacturer
- Novartis Gene Therapies, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125694
- Marketing Start
- 05/24/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Zolgensma used for?
Zolgensma contains onasemnogene abeparvovec-xioi. It is a kit taken as directed. Consult your doctor for specific uses.
Is Zolgensma a controlled substance?
Zolgensma is not classified as a controlled substance by the DEA.
What is the generic name for Zolgensma?
The generic name for Zolgensma is onasemnogene abeparvovec-xioi. There are no other listed brand versions of onasemnogene abeparvovec-xioi.
What is the NDC code for Zolgensma ?
The NDC (National Drug Code) for Zolgensma is 71894-149, listed by Novartis Gene Therapies, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)